An open-label, unit dose-finding study evaluating the safety and platelet response of a novel thrombopoietic protein (AMG531) in thrombocytopenic adult patients (Pts) with immune thrombocytopenic purpura (ITP).

被引：9

作者：

Newland, A

Caulier, MT

Schipperus, MR

Kappers-Klunne, M

Varet, BR

Watkins, K

Chen, CF

Nichol, JL

机构：

[1] Hop Necker Enfants Malad, Paris, France

[2] Erasmus MC, Rotterdam, Netherlands

[3] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

[4] HagaZiekenhuis, The Hague, Netherlands

[5] Ctr Hosp Henri Mondor, Creteil, France

[6] Univ London St Bartholomews Hosp Med Coll, Queen Marys Sch Med, London, England

[7] Amgen Inc, Thousand Oaks, CA 91320 USA

[8] Hosp Claude Huriez, Lille, France

[9] Amgen LTD, Cambridge, England

来源：

关键词：

D O I：

10.1182/blood.V104.11.2058.2058

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2058

引用

页码：567A / 567A

页数：1